1987
DOI: 10.1021/bi00379a011
|View full text |Cite
|
Sign up to set email alerts
|

Studies of the active site of cytochrome P-450 scc with a high-affinity spin-labeled inhibitor

Abstract: The intramolecular site of P-450scc for conversion of cholesterol to pregnenolone involves a substrate site, an active site, and a site for transmission of electrons. The substrate site was studied with a high-affinity, high-potency nitroxide spin-labeled inhibitor of cholesterol side-chain cleavage. This substance, 17 alpha-hydroxy-11-deoxycorticosterone nitroxide (SL-V), has an affinity comparable to that of the most active substrate inhibitors ever reported and 2-50 times greater than that of the natural su… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
7
0

Year Published

1988
1988
2008
2008

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 22 publications
0
7
0
Order By: Relevance
“…Since, as discussed above, the doxyl ring is too far away from the heme to perturb the iron electronic environment by direct electromagnetic interaction, the spin probe may exert a constraint upon the heme via the protein structure. Interestingly, the binding of a side-chain spin-labelled deoxycorticosterone derivative, which is not a substrate for cytochrome P-450,,,, does not induce a change of the heme-iron ESR g-values [15]. In contrast, the orientation of the CNO molecule within the enzyme active site is more likely that of authentic cholesterol, due to the substrate nature of CNO.…”
Section: Discussionmentioning
confidence: 89%
See 3 more Smart Citations
“…Since, as discussed above, the doxyl ring is too far away from the heme to perturb the iron electronic environment by direct electromagnetic interaction, the spin probe may exert a constraint upon the heme via the protein structure. Interestingly, the binding of a side-chain spin-labelled deoxycorticosterone derivative, which is not a substrate for cytochrome P-450,,,, does not induce a change of the heme-iron ESR g-values [15]. In contrast, the orientation of the CNO molecule within the enzyme active site is more likely that of authentic cholesterol, due to the substrate nature of CNO.…”
Section: Discussionmentioning
confidence: 89%
“…Obviously the orientation of the CNO molecule within the cytochrome P-450,,, active site is very similar to that of authentic cholesterol. This is of particular interest, since previous investigations of the steroid binding site were undertaken mostly with P-450,,, inhibitors such as amino-cholesterols [5 -81, suicide substrates or recently with a spin-labeled deoxycorticosterone derivative [15]. CNO, on the contrary, may be used as a suitable spin-labelled substrate analogue for the study of the enzyme-substrate interaction in the course of the catalytic event.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…(2) The center of the cholesterol molecule should be as close as possible to the heme because experimental data show that, in the productive complex, the C22 atom of cholesterol located near the center of the molecule should be close to the heme iron. [42][43][44][45] Application of the first criterion left only 4 out of 12 possible regions for cholesterol contact. Those regions comprised the following residues: (1) Pro131, Leu132, Pro135, and the adjacent Ile130, Leu267, and Val424 (region 1); (2) Ile245, Phe246, Leu250, and the adjacent Leu184 (region 2); (3) Ile409, Leu414, Trp418, and the adjacent Phe390 (region 3); (4) Ile468, Phe469, Leu470, Val471, and the adjacent Leu164 (region 4).…”
Section: Uv-visible Studymentioning
confidence: 99%